## Summary
[DOLPP1](/details-gene/57171), or dolichyldiphosphatase 1, is a protein-coding gene located on human chromosome 9q34.11. The gene encodes an enzyme that exhibits [dolichyldiphosphatase activity](/details-go/GO:0047874) and resides within the [endoplasmic reticulum membrane](/details-go/GO:0005789). Its primary function is integral to the process of [protein n-linked glycosylation](/details-go/GO:0006487), a critical post-translational modification essential for the proper folding, stability, and function of many proteins. Expression data indicates that [DOLPP1](/details-gene/57171) is particularly significant in secretory and structurally complex cells, with high expression observed in [colon epithelial cell](/details-cell/CL0011108) and various neuronal populations. The discovery and characterization of this gene were part of large-scale cDNA and genome sequencing projects ([Link](https://doi.org/10.1038/ng1285), [Link](https://doi.org/10.1038/nature02465)).
## Cellular Roles and Expression Landscape
The expression profile of [DOLPP1](/details-gene/57171) suggests a specialized role in metabolically active cells with high rates of protein synthesis and secretion.
**Overall**, the gene shows its highest significance in distinct cell populations from the epithelial and nervous systems. The top-ranked cell types include:
* [colon epithelial cell](/details-cell/CL0011108) (CSI: 2.87)
* [peripheral nervous system neuron](/details-cell/CL2000032) (CSI: 2.63)
* [caudal ganglionic eminence derived cortical interneuron](/details-cell/CL4023064) (CSI: 2.20)
The high significance in [colon epithelial cell](/details-cell/CL0011108) is consistent with the extensive N-linked glycosylation required for the production of mucins and the maintenance of cell-surface receptors that form the intestinal barrier. In the nervous system, its prominent role in both [peripheral nervous system neuron](/details-cell/CL2000032) and specific central nervous system interneurons like the [caudal ganglionic eminence derived cortical interneuron](/details-cell/CL4023064) suggests a critical function in synthesizing and modifying the vast array of glycoproteins necessary for synaptic transmission, ion channel function, and neural circuit integrity.
## Pathways and Molecular Function
The molecular function of [DOLPP1](/details-gene/57171) is centered on the N-linked glycosylation pathway, a fundamental process for protein modification. Its involvement is detailed in several key biological pathways and processes.
**Gene Ontology (GO) annotations highlight its specific roles:**
* **Biological Process:** It is a key component of the [dolichyl diphosphate biosynthetic process](/details-go/GO:0006489) and, more broadly, [protein n-linked glycosylation](/details-go/GO:0006487).
* **Molecular Function:** It possesses [dolichyldiphosphatase activity](/details-go/GO:0047874), which involves the dephosphorylation of dolichyl diphosphate to dolichyl phosphate, a critical step in the recycling of the lipid carrier for glycan synthesis.
* **Cellular Component:** Its activity is localized to the [endoplasmic reticulum membrane](/details-go/GO:0005789), the primary site of N-linked glycosylation.
**Reactome pathway analysis further clarifies its integration into cellular metabolism:**
* It is a core enzyme in [Asparagine n-linked glycosylation](/details-pathway/R-HSA-446203) and the [synthesis of substrates in n-glycan biosythesis](/details-pathway/R-HSA-446219).
* Specifically, it participates in the [synthesis of dolichyl-phosphate](/details-pathway/R-HSA-446199) and the overall [biosynthesis of the n-glycan precursor (dolichol lipid-linked oligosaccharide, llo) and transfer to a nascent protein](/details-pathway/R-HSA-446193).
These functions are foundational to broader processes such as [Metabolism of proteins](/details-pathway/R-HSA-392499) and [Post-translational protein modification](/details-pathway/R-HSA-597592), underscoring the gene's importance in maintaining cellular proteostasis, particularly in the cell types where it is highly expressed.
## Research Directions
The specific expression pattern and fundamental function of [DOLPP1](/details-gene/57171) suggest several avenues for future research, particularly concerning its role in tissue homeostasis and disease.
**Proposed Testable Hypotheses:**
1. **Role in Neuropathies:** Given its high significance in [peripheral nervous system neuron](/details-cell/CL2000032), it is hypothesized that mutations or dysregulation of [DOLPP1](/details-gene/57171) could lead to congenital disorders of glycosylation that manifest as peripheral neuropathies due to the improper glycosylation of critical neuronal proteins like ion channels and myelin-associated glycoproteins.
2. **Function in Intestinal Barrier Integrity:** The high CSI score in [colon epithelial cell](/details-cell/CL0011108) suggests a critical role in gut health. We hypothesize that reduced [DOLPP1](/details-gene/57171) activity impairs the glycosylation of mucin proteins, compromising the integrity of the colonic mucus layer and increasing susceptibility to inflammatory bowel diseases (IBD).
**Suggested Experimental Approach:**
To test the second hypothesis regarding intestinal barrier function, a conditional knockout mouse model could be generated where [DOLPP1](/details-gene/57171) is specifically deleted in intestinal epithelial cells (e.g., using a Villin-Cre driver). These mice could be compared to wild-type littermates to assess:
* **Mucus Layer Integrity:** Analysis of the colonic mucus layer thickness and composition using histological stains (e.g., Alcian blue) and lectin histochemistry to detect changes in glycan structures.
* **Barrier Permeability:** In vivo intestinal permeability could be quantified using oral administration of FITC-dextran and measuring its concentration in serum.
* **Susceptibility to Colitis:** Mice could be challenged with dextran sodium sulfate (DSS) in their drinking water to induce colitis, with disease severity monitored by weight loss, colon length, and histological scoring.
**Therapeutic Potential:**
As an enzyme involved in a fundamental metabolic pathway, [DOLPP1](/details-gene/57171) presents a challenging therapeutic target. Systemic **inhibition** would likely cause severe toxicity due to the universal requirement for N-linked glycosylation. However, certain pathologies, such as cancers originating from highly secretory tissues (e.g., colorectal cancer), may exhibit an "addiction" to the glycosylation pathway to support rapid growth and metastasis. In such contexts, developing highly specific small-molecule inhibitors of [DOLPP1](/details-gene/57171) could be a viable strategy, potentially as part of a combination therapy to selectively target cancer cells that have an upregulated glycosylation flux.
Disclaimer: This in-silico analysis is generated by an AI language model and may contain inaccuracies or hallucinations. However, it is cross-referenced with curated gene expression data from major biological sources. Please verify the information before use.
